Looking for a stock that might be in a good position to beat earnings at its next report? Consider Cempra, Inc. (CEMP), a firm in the Medical-Drugs industry, which could be a great candidate for ...
) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Cempra as such a stock due to the following factors: ...
) as a strong on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Cempra as such a stock due to the following factors: CEMP has an average ...
Shares of Cempra, Inc. CEMP plunged 57.3% after the company announced that it received a Complete Response Letter (CRL) from the FDA relating to the company’s new drug applications (NDAs) for oral and ...
Cempra Inc (NASDAQ:CEMP) just announced that it may not meet its PDUFA for solithromycin, and the company has taken a big hit on the news. The response is somewhat justifiable – the implications of ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results